Page last updated: 2024-12-07

sk&f 95654

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

SK&F 95654: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID130702
SCHEMBL ID6212361
MeSH IDM0167780

Synonyms (14)

Synonym
sb-95654
sk&f 95654
3(2h)-pyridazinone, 4,5-dihydro-5-methyl-6-(4-(4-oxo-1(4h)-pyridinyl)phenyl)-
sb 95654
sk&f-95654
skf 95654
4-methyl-3-[4-(4-oxopyridin-1-yl)phenyl]-4,5-dihydro-1h-pyridazin-6-one
112127-66-9
SCHEMBL6212361
5-methyl-6-[4-(4-oxo-1,4-dihydropyridin-1-yl)phenyl]-4,5-dihydro-3(2h)-pyridazinone
OOTPDLYEDHRWNL-UHFFFAOYSA-N ,
1-[4-(6-hydroxy-4-methyl-4,5-dihydropyridazin-3-yl)phenyl]pyridin-4(1h)-one
DTXSID80920671
skf95654

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Myocardial lesions and vascular lesions of the mesentery, spleen, and pancreas were seen 24 hours after dosing with either 50,100, or 200 mg/kg SK&F 95654."( SK&F 95654-induced acute cardiovascular toxicity in Sprague-Dawley rats--histopathologic, electron microscopic, and immunohistochemical studies.
Chadwick, DP; Ferrans, VJ; Herman, EH; Knapton, A; Koerner, JE; Papoian, T; Sistare, FD; Whitehurst, VE; Zhang, J,
)
1.77
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.51 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]